APO RESEARCH · REPORT
Pediculosis and Pthiriasis (Lice Infestation) Treatment
Selected research
Market Outlook & Growth Opportunities
Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Outlook and Growth Opportunities 2026
Market perspective
The global Pediculosis and Pthiriasis (Lice Infestation) Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Pediculosis and Pthiriasis (Lice Infestation) Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pediculosis and Pthiriasis (Lice Infestation) Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pediculosis and Pthiriasis (Lice Infestation) Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Pediculosis and Pthiriasis (Lice Infestation) Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Pediculosis and Pthiriasis (Lice Infestation) Treatment market include Actavis, Arborpharma, Logic Products, Major Pharmaceuticals, Omega Pharma, ParaPRO, Perrigo, Prestige Brands and Reckitt Benckier, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Pediculosis and Pthiriasis (Lice Infestation) Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pediculosis and Pthiriasis (Lice Infestation) Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pediculosis and Pthiriasis (Lice Infestation) Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pediculosis and Pthiriasis (Lice Infestation) Treatment market.
Pediculosis and Pthiriasis (Lice Infestation) Treatment Segment by Company
Actavis
Arborpharma
Logic Products
Major Pharmaceuticals
Omega Pharma
ParaPRO
Perrigo
Prestige Brands
Reckitt Benckier
Shionogi
TecLabs
Thornton and Ross
Tianren
Tyratech
Bayer
Pediculosis and Pthiriasis (Lice Infestation) Treatment Segment by Type
Lotion
Shampoo
Creams
Other
Pediculosis and Pthiriasis (Lice Infestation) Treatment Segment by Application
Children
Adult
Pediculosis and Pthiriasis (Lice Infestation) Treatment Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Pediculosis and Pthiriasis (Lice Infestation) Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Pediculosis and Pthiriasis (Lice Infestation) Treatment key companies, revenue, market share, and recent developments.
3. To split the Pediculosis and Pthiriasis (Lice Infestation) Treatment breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Pediculosis and Pthiriasis (Lice Infestation) Treatment market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pediculosis and Pthiriasis (Lice Infestation) Treatment significant trends, drivers, influence factors in global and regions.
6. To analyze Pediculosis and Pthiriasis (Lice Infestation) Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediculosis and Pthiriasis (Lice Infestation) Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pediculosis and Pthiriasis (Lice Infestation) Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediculosis and Pthiriasis (Lice Infestation) Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pediculosis and Pthiriasis (Lice Infestation) Treatment industry.
Chapter 3: Detailed analysis of Pediculosis and Pthiriasis (Lice Infestation) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Pediculosis and Pthiriasis (Lice Infestation) Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Pediculosis and Pthiriasis (Lice Infestation) Treatment in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Lotion
- Shampoo
- Creams
- Other
Applications
- Children
- Adult
Companies covered
- Actavis
- Arborpharma
- Logic Products
- Major Pharmaceuticals
- Omega Pharma
- ParaPRO
- Perrigo
- Prestige Brands
- Reckitt Benckier
- Shionogi
- TecLabs
- Thornton and Ross
- Tianren
- Tyratech
- Bayer
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Dynamics
- 2.1 Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Trends
- 2.2 Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Drivers
- 2.3 Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Opportunities and Challenges
- 2.4 Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Restraints
3 Pediculosis and Pthiriasis (Lice Infestation) Treatment Market by Company
- 3.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Company Revenue Ranking in 2025
- 3.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Company (2021-2026)
- 3.3 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Company Ranking (2024-2026)
- 3.4 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Company Manufacturing Base and Headquarters
- 3.5 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Company Product Type and Application
- 3.6 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Pediculosis and Pthiriasis (Lice Infestation) Treatment Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Pediculosis and Pthiriasis (Lice Infestation) Treatment Market by Type
- 4.1 Pediculosis and Pthiriasis (Lice Infestation) Treatment Type Introduction
- 4.1.1 Lotion
- 4.1.2 Shampoo
- 4.1.3 Creams
- 4.1.4 Other
- 4.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Type
- 4.2.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Type (2021-2032)
- 4.2.3 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type (2021-2032)
5 Pediculosis and Pthiriasis (Lice Infestation) Treatment Market by Application
- 5.1 Pediculosis and Pthiriasis (Lice Infestation) Treatment Application Introduction
- 5.1.1 Children
- 5.1.2 Adult
- 5.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Application
- 5.2.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Application (2021-2032)
- 5.2.3 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application (2021-2032)
6 Pediculosis and Pthiriasis (Lice Infestation) Treatment Regional Value Analysis
- 6.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Region (2021-2032)
- 6.2.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Region: 2021-2026
- 6.2.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value (2021-2032)
- 6.3.2 North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value (2021-2032)
- 6.4.2 Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value (2021-2032)
- 6.6.2 South America Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Country, 2025 VS 2032
7 Pediculosis and Pthiriasis (Lice Infestation) Treatment Country-level Value Analysis
- 7.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Country (2021-2032)
- 7.2.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Country (2021-2026)
- 7.2.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.7.2 France Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.14.2 China Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.17.2 India Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Actavis
- 8.1.1 Actavis Company Information
- 8.1.2 Actavis Business Overview
- 8.1.3 Actavis Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
- 8.1.4 Actavis Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
- 8.1.5 Actavis Recent Developments
- 8.2 Arborpharma
- 8.2.1 Arborpharma Company Information
- 8.2.2 Arborpharma Business Overview
- 8.2.3 Arborpharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
- 8.2.4 Arborpharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
- 8.2.5 Arborpharma Recent Developments
- 8.3 Logic Products
- 8.3.1 Logic Products Company Information
- 8.3.2 Logic Products Business Overview
- 8.3.3 Logic Products Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
- 8.3.4 Logic Products Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
- 8.3.5 Logic Products Recent Developments
- 8.4 Major Pharmaceuticals
- 8.4.1 Major Pharmaceuticals Company Information
- 8.4.2 Major Pharmaceuticals Business Overview
- 8.4.3 Major Pharmaceuticals Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
- 8.4.4 Major Pharmaceuticals Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
- 8.4.5 Major Pharmaceuticals Recent Developments
- 8.5 Omega Pharma
- 8.5.1 Omega Pharma Company Information
- 8.5.2 Omega Pharma Business Overview
- 8.5.3 Omega Pharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
- 8.5.4 Omega Pharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
- 8.5.5 Omega Pharma Recent Developments
- 8.6 ParaPRO
- 8.6.1 ParaPRO Company Information
- 8.6.2 ParaPRO Business Overview
- 8.6.3 ParaPRO Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
- 8.6.4 ParaPRO Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
- 8.6.5 ParaPRO Recent Developments
- 8.7 Perrigo
- 8.7.1 Perrigo Company Information
- 8.7.2 Perrigo Business Overview
- 8.7.3 Perrigo Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
- 8.7.4 Perrigo Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
- 8.7.5 Perrigo Recent Developments
- 8.8 Prestige Brands
- 8.8.1 Prestige Brands Company Information
- 8.8.2 Prestige Brands Business Overview
- 8.8.3 Prestige Brands Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
- 8.8.4 Prestige Brands Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
- 8.8.5 Prestige Brands Recent Developments
- 8.9 Reckitt Benckier
- 8.9.1 Reckitt Benckier Company Information
- 8.9.2 Reckitt Benckier Business Overview
- 8.9.3 Reckitt Benckier Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
- 8.9.4 Reckitt Benckier Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
- 8.9.5 Reckitt Benckier Recent Developments
- 8.10 Shionogi
- 8.10.1 Shionogi Company Information
- 8.10.2 Shionogi Business Overview
- 8.10.3 Shionogi Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
- 8.10.4 Shionogi Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
- 8.10.5 Shionogi Recent Developments
- 8.11 TecLabs
- 8.11.1 TecLabs Company Information
- 8.11.2 TecLabs Business Overview
- 8.11.3 TecLabs Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
- 8.11.4 TecLabs Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
- 8.11.5 TecLabs Recent Developments
- 8.12 Thornton and Ross
- 8.12.1 Thornton and Ross Company Information
- 8.12.2 Thornton and Ross Business Overview
- 8.12.3 Thornton and Ross Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
- 8.12.4 Thornton and Ross Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
- 8.12.5 Thornton and Ross Recent Developments
- 8.13 Tianren
- 8.13.1 Tianren Company Information
- 8.13.2 Tianren Business Overview
- 8.13.3 Tianren Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
- 8.13.4 Tianren Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
- 8.13.5 Tianren Recent Developments
- 8.14 Tyratech
- 8.14.1 Tyratech Company Information
- 8.14.2 Tyratech Business Overview
- 8.14.3 Tyratech Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
- 8.14.4 Tyratech Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
- 8.14.5 Tyratech Recent Developments
- 8.15 Bayer
- 8.15.1 Bayer Company Information
- 8.15.2 Bayer Business Overview
- 8.15.3 Bayer Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
- 8.15.4 Bayer Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
- 8.15.5 Bayer Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst